Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19. Vol. 58 - Rhoads, D D; Cherian, S S; Roman, K; Stempak, L M; Schmotzer, C L; Sadri, N (2020)
J Clin Microbiol